PyInvesting

Market research

SHALBY.NSE Shalby Limited

NSE INR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
16B
P/E ratio
41.37
Analyst target
310
Dividend yield
Not available
Beta
0.62

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Shalby Limited is currently in a long term uptrend where the price is trading 64.7% above its 200 day moving average.

From a valuation standpoint, the stock is 37.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.

Shalby Limited's total revenue rose by 9.1% to $1B since the same quarter in the previous year.

Its net income has increased by 106.5% to $168M since the same quarter in the previous year.

Finally, its free cash flow fell by 38.7% to $158M since the same quarter in the previous year.

Based on the above factors, Shalby Limited gets an overall score of 4/5.